` AJJ (Asian American Medical Group Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

AJJ
vs
S
S&P/ASX 300

Over the past 12 months, AJJ has underperformed S&P/ASX 300, delivering a return of 0% compared to the S&P/ASX 300's +7% growth.

Stocks Performance
AJJ vs S&P/ASX 300

Loading
AJJ
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
AJJ vs S&P/ASX 300

Loading
AJJ
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
AJJ vs S&P/ASX 300

Loading
AJJ
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Asian American Medical Group Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Asian American Medical Group Ltd
Glance View

Market Cap
14.5m AUD
Industry
Health Care

Asian American Medical Group Ltd. provides healthcare consultancy and management services. The firm's segments include liver, Multi-Specialty, Healthcare Management and Consultancy, and Healthcare Real Estate. The liver segment operates is engaged in the business of treatment of all liver, pancreas and bile duct diseases in adults and children. The Multi-Specialty segment is a medical specialist in Singapore and abroad, mainly in the United States and Great Britain. The Multi-Specialty, Healthcare Management and Consultancy segment is focused on sourcing and identifying potential healthcare-related projects. THe Healthcare Real Estate segment is managed under the Company’s subsidiary Asian American Healthcare Ventures Pte Ltd (AAHV).

AJJ Intrinsic Value
Not Available
Back to Top